Jennifer Kathleen Bielasz - Net Worth and Insider Trading

Jennifer Kathleen Bielasz Net Worth

The estimated net worth of Jennifer Kathleen Bielasz is at least $48,295 dollars as of 2024-04-25. Jennifer Kathleen Bielasz is the Sr.Dir. of Acct. & Cont. (PAO) of Arena Pharmaceuticals Inc and owns about 483 shares of Arena Pharmaceuticals Inc (ARNA) stock worth over $48,295. Details can be seen in Jennifer Kathleen Bielasz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jennifer Kathleen Bielasz has not made any transactions after 2012-03-29 and currently still holds the listed stock(s).

Transaction Summary of Jennifer Kathleen Bielasz

To

Jennifer Kathleen Bielasz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer Kathleen Bielasz owns 1 companies in total, including Arena Pharmaceuticals Inc (ARNA) .

Click here to see the complete history of Jennifer Kathleen Bielasz’s form 4 insider trades.

Insider Ownership Summary of Jennifer Kathleen Bielasz

Ticker Comapny Transaction Date Type of Owner
ARNA Arena Pharmaceuticals Inc 2016-03-02 VP & Finance and Accounting

Jennifer Kathleen Bielasz Latest Holdings Summary

Jennifer Kathleen Bielasz currently owns a total of 1 stock. Jennifer Kathleen Bielasz owns 483 shares of Arena Pharmaceuticals Inc (ARNA) as of March 29, 2012, with a value of $48,295.

Latest Holdings of Jennifer Kathleen Bielasz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARNA Arena Pharmaceuticals Inc 2012-03-29 483 99.99 48,295

Holding Weightings of Jennifer Kathleen Bielasz


Jennifer Kathleen Bielasz Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennifer Kathleen Bielasz has made a total of 0 transactions in Arena Pharmaceuticals Inc (ARNA) over the past 5 years. The most-recent trade in Arena Pharmaceuticals Inc is the sale of 1,080 shares on March 29, 2012, which brought Jennifer Kathleen Bielasz around $32,724.

Insider Trading History of Jennifer Kathleen Bielasz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennifer Kathleen Bielasz Trading Performance

GuruFocus tracks the stock performance after each of Jennifer Kathleen Bielasz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jennifer Kathleen Bielasz is 20%. GuruFocus also compares Jennifer Kathleen Bielasz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jennifer Kathleen Bielasz within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jennifer Kathleen Bielasz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jennifer Kathleen Bielasz

Average Return

338.22%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.69 20 282.56 338.22 80.17 30.29
Relative Return to S&P 500(%) -11.47 13.83 278.69 323.98 64.14 15.63

Jennifer Kathleen Bielasz Ownership Network

Ownership Network List of Jennifer Kathleen Bielasz

No Data

Ownership Network Relation of Jennifer Kathleen Bielasz


Jennifer Kathleen Bielasz Owned Company Details

What does Arena Pharmaceuticals Inc do?

Who are the key executives at Arena Pharmaceuticals Inc?

Jennifer Kathleen Bielasz is the VP & Finance and Accounting of Arena Pharmaceuticals Inc. Other key executives at Arena Pharmaceuticals Inc include director & President and CEO Amit Munshi , EVP & Chief Commercial Officer Robert Lisicki , and Executive VP and CBO Vincent Aurentz .

Arena Pharmaceuticals Inc (ARNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arena Pharmaceuticals Inc Insider Transactions

No Available Data

Jennifer Kathleen Bielasz Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer Kathleen Bielasz. You might contact Jennifer Kathleen Bielasz via mailing address: C/o Arena Pharmaceuticals, Inc. San Diego Ca 92121.

Discussions on Jennifer Kathleen Bielasz

No discussions yet.